From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds | Minimum inhibitory concentration (µg/ml) | ||||||
---|---|---|---|---|---|---|---|
M. luteus | S. aureus | S. aureus | B. subtilis | E. coli | P. aeruginosa | K. planticola | |
a22 | 7.8 | 15.6 | 15.6 | 15.6 | 7.8 | 7.8 | 15.6 |
a23 | >Â 250 | 15.6 | 7.8 | 15.6 | 15.6 | 15.6 | 7.8 |
a24 | 15.6 | 7.8 | 7.8 | 15.6 | 7.8 | 7.8 | 7.8 |
Ciprofloxacin | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |